{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:alidornase alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02957266: Phase 3 Interventional Unknown status Cervical Cancer
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:bremzalerbart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00152477: Phase 2 Interventional Completed Carcinoma
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:efranarelaxin alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02312206: Phase 3 Interventional Terminated Primary Systemic (AL) Amyloidosis
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01638936: Phase 1/Phase 2 Interventional Completed Multiple Myeloma
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01063803: Phase 2 Interventional Completed Rheumatoid Arthritis
(2010)
Source URL:
Class:
PROTEIN
